Oral treatment with β‐lactoglobulin peptides prevents clinical symptoms in a mouse model for cow's milk allergy

Abstract

Prior exposure to specific peptides of β-lactoglobulin reduces the allergic response to whey, which may involve regulatory dendritic and T cells. Combining peptides with a sGOS/lcFOS/pAOS-containing diet enhances this effect.